25431108
2015 May
The aim of this study was to determine the long-term efficacy of entecavir (ETV) and tenofovir disoproxil fumarate (TDF) on the natural course of disease in chronic hepatitis B patients (CHB) with/without cirrhosis in clinical practice. A total of 355 treatment-na√Øve CHB patients were enrolled into the study. The primary outcome measure was viral suppression as defined by serum HBV DNA level
chronic hepatitis B; entecavir; hepatocellular carcinoma; tenofovir disoproxil fumarate.
